Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a ß-Lactamase-Activated Antibacterial Prodrug. (2019)
Attributed to:
BristolBridge: Bridging the Gaps between the Engineering and Physical Sciences and Antimicrobial Resistance
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.8b01923
PubMed Identifier: 31009558
Publication URI: http://europepmc.org/abstract/MED/31009558
Type: Journal Article/Review
Volume: 62
Parent Publication: Journal of medicinal chemistry
Issue: 9
ISSN: 0022-2623